Gene Schaefer is currently a Senior Fellow at The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). Prior to that he held a number of roles in the Biopharmaceutical Industry over the last 35+ years. Most recently he was Senior Director, API Large Molecule BioTherapeutics Development at Janssen R&D, the pharmaceutical division of Johnson & Johnson, responsible for early-stage process development through commercial product support for protein therapeutics. Before that, he held roles of increasing responsibility in the process development and manufacturing of protein therapeutics, viral vectors, and carbohydrate products at Bristol-Myers Squibb, Schering Plough, and Genzyme.
He received a B.S. degree in Chemical Engineering from Princeton University and M.S. and Sc.D. degrees in Biochemical Engineering from M.I.T. He is currently an adjunct professor of Chemical and Biomolecular Engineering at the University of Delaware and a member of the Board of Directors for Engineering Conferences International (ECI) as well as the Advisory Board for the New Jersey Center for Science, Technology, and Mathematics at Kean University where he helped start the Biotechnology MS degree program in 2001.